Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era

Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era

Emerging evidence indicates that thromboembolic complications are a key determinant of inhospital mortality of patients with COVID-19. Prophylactic anticoagulation therapy is an important component of inhospital management of patients with COVID-19. Considering that millions of patients worldwide ar...

Full description

Bibliographic Details
Main Authors: Heng Cai, Xin Zhou, Qing Yang
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2020-01-01
Series:Cardiology Plus
Subjects:
covid-19; non-vitamin k antagonist oral anticoagulants; oral anticoagulant; warfarin
Online Access:http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2020;volume=5;issue=4;spage=171;epage=174;aulast=Cai

Internet

http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2020;volume=5;issue=4;spage=171;epage=174;aulast=Cai

Similar Items